NCT05516797View on ClinicalTrials.gov

IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE)

NACompletedINTERVENTIONAL

Enrollment

178

Participants

Timeline

Start Date

September 22, 2022

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions

Type 2 Diabetes

Interventions

DEVICE

Continuous Glucose Monitoring (CGM)

Use of CGM (FreeStyle Libre 2) compared to BGM for glucose monitoring

Trial Locations (1)

55416

Health Partners Institute dba International Diabetes Center, Minneapolis

Sponsors

Collaborators (1)

Abbott Diabetes Care

All Listed Sponsors

collaborator

Virta Health

INDUSTRY

collaborator

Abbott Diabetes Care

INDUSTRY

lead

HealthPartners Institute

OTHER

NCT05516797 - IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE) | Biotech Hunter | Biotech Hunter